Every material Form 8-K Perdoceo Education filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Perdoceo reported third-quarter 2025 revenue up 24.8% to $211.9 million and GAAP diluted earnings per share of $0.60, compared with $0.57 a year earlier, and provided full-year 2025 GAAP EPS guidance of $2.35 to $2.37. The results include the USAHS acquisition completed on December 2, 2024, and the company returned $30.3 million to shareholders in the quarter through buybacks and dividends.
Q3 revenue rose 24.8% to $211.9 million; operating income rose 13.8% to $51.0 million.
Q3 GAAP diluted EPS was $0.60 versus $0.57; adjusted diluted EPS was $0.65 versus $0.59.
Full-year 2025 GAAP EPS outlook is $2.35 to $2.37, versus $2.19 for 2024; Q4 outlook is $0.48 to $0.50 versus $0.47.
Board declared a quarterly dividend of $0.15 per share, payable December 12, 2025.
Perdoceo Education reported second-quarter 2025 revenue of $209.6 million, up 25.7% from $166.7 million a year earlier, and GAAP diluted earnings per share of $0.62 versus $0.57. The board also raised the quarterly dividend 15.4% to $0.15 per share and approved a new $75.0 million share buyback, while the full-year 2025 GAAP earnings per share outlook of $2.29 to $2.36 compares with $2.19 in 2024.
Q2 2025 revenue $209.6 million, up 25.7% from $166.7 million; operating income $51.4 million, up 11.7%.
GAAP diluted EPS $0.62 for the quarter versus $0.57; year to date $1.27 versus $1.16.
Full-year 2025 GAAP EPS outlook $2.29 to $2.36 versus $2.19 in 2024; third-quarter outlook $0.55 to $0.57 versus $0.57.
Quarterly dividend raised to $0.15 per share, payable September 12, 2025; new $75.0 million buyback runs through January 31, 2027.
Perdoceo Education reported first-quarter 2025 revenue of $213.0 million, up 26.6%, and diluted earnings per share of $0.65 versus $0.59 a year earlier, with the USAHS acquisition and CTU enrollment growth cited as drivers. The company also updated its 2025 outlook, with full-year GAAP diluted EPS guided to $2.21 to $2.37 and second-quarter EPS to $0.59 to $0.61.
Revenue was $213.0 million, up from $168.3 million; USAHS contributed $39.2 million.
Diluted EPS was $0.65 versus $0.59; adjusted diluted EPS was $0.70 versus $0.60.
2025 GAAP diluted EPS outlook is $2.21 to $2.37; second-quarter outlook is $0.59 to $0.61.
Cash and investments totaled $612.2 million at March 31, 2025; the company repurchased $25.2 million of stock and declared a $0.13 quarterly dividend payable June 13, 2025.
On March 6, 2025, Perdoceo's compensation committee approved a 2025 Annual Incentive Plan similar to its 2024 plan, and approved pay increases for the CEO, CFO and general counsel effective March 1, 2025. The changes are compensation matters that do not alter reported results, and they show the board's pay structure for senior executives for the year.
2025 AIP weights adjusted operating income at 80% and individual goals at 20% for senior participants
Payouts require a threshold adjusted operating income level and are capped at 200% of target
CEO Todd Nelson's base salary rose 6.25% to $850,000; general counsel Greg Jansen's rose 6.05% to $412,000
CFO Ashish Ghia's long-term incentive target rose 20% to 180% of base salary
Perdoceo reported fourth-quarter 2024 revenue of $176.4 million, up 19.3%, and diluted EPS of $0.47 versus $0.26. For the full year, revenue fell 4.0% to $681.3 million while diluted EPS was $2.19 versus $2.18, and the company gave a 2025 full-year diluted EPS outlook of $2.11 to $2.31.
Q4 2024 operating income rose 133.2% to $37.2 million; full-year operating income rose 15.8% to $174.3 million.
Full-year 2024 adjusted diluted EPS was $2.29 versus $2.10 a year earlier; the company completed the USAHS acquisition in December 2024.
2025 outlook: full-year operating income of $172.0 million to $192.0 million and diluted EPS of $2.11 to $2.31.
Board declared a quarterly dividend of $0.13 per share, payable March 13, 2025 to holders of record on March 1, 2025.
Perdoceo Education Corporation appointed Hanna Skandera to its Board of Directors on February 3, 2025, after the Board voted to expand its eligible seats from eight to nine. The appointment is a board change with no financial results reported, and the filing describes her compensation as a non-employee director.
Board appointment effective February 3, 2025; term runs to the 2025 annual meeting of stockholders
Annual cash retainer of $80,000 plus an annual restricted stock unit grant with a $125,000 target value at grant
Prorated equity award with a $31,250 target value, scheduled for February 21, 2025, vesting March 14, 2026
Ms. Skandera has not yet been named to any Board committee
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Perdoceo Education filing is on SEC EDGAR ↗. 8-K briefs of other companies →